Archive
International News Services archives articles supplied to clients one year or more after initial publication. These articles are protected by a password and not made available to readers without permission from clients. They are used as a background resource by agency journalists. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.
CHINA TOURISTS
BY ALAN OSBORN
A SIGNIFICANT increase in the number of Chinese tourists coming to Europe is expected to follow the signing of an agreement between the European Union (EU) and the China National Tourism Administration (CNTA) that will simplify and ease the tourist visa procedures for visitors to Approved Destination Status (ADS) countries.…
ECJ - AUSTRIA
BY KEITH NUTHALL
PUNITIVE tolls levied on Austria’s trans-Alpine Brenner motorway have been undermined by a European Court of Justice (ECJ) ruling, which has opened the way for hauliers to claim compensation against their effect. The decision is a precedent across the European Union and could be used to challenge other punitive tolls, designed to dissuade hauliers from using environmentally sensitive routes.…
NEUROLOGICAL STUDY
BY KEITH NUTHALL
AN INTERNATIONAL study involving 40 research facilities is trying to discover whether there is one key cause of all degenerative neurological diseases, such as Alzheimer’s. The APOPIS (abnormal proteins in the pathogenesis of neurodegenerative disorders) project has received Euro 9 million in European Union research funding.…
RUSSIA PACKAGING
BY KEITH NUTHALL
THE EUROPEAN Bank for Reconstruction and Development (EBRD) has drawn up plans to lend Euro 22 million to Serbia & Montenegro pharmaceutical company Hemofarm Koncern a.d. (Hemofarm) to finance the construction of a new solid forms packaging and production facility in Obninsk, Russia.…
US-AUSTRALIA DEAL
BY KEITH NUTHALL
THE PHARMACEUTICAL sector is a key element of a free trade agreement recently struck between the USA and Australia, although some onlookers claim Washington failed to achieve many of its aims regarding the industry. Nonetheless, the US Trade Representative’s office lauded the fact that Australia would make product-listing procedures within its pharmaceuticals benefits scheme more transparent, notably through the creation of an independent review process.…
EMEA ORPHANS
BY KEITH NUTHALL
ADVICE has been released by the European Agency for the Evaluation of Medicinal Products (EMEA) on the impact that May’s enlargement of the European Union (EU) will have on new marketing applications for orphan drugs. It also addresses the affect on existing designations, translations and transitional arrangements for the period before May.…
EMEA LANGUAGES
BY KEITH NUTHALL
GUIDELINES have been issued by the European Agency for the Evaluation of Medicinal Products (EMEA) on how pharmaceutical companies should use the new European Union (EU) official languages adopted because of May’s accession of 10 Member States. Applications for EU marketing approvals must henceforth include assessments translated into the expanded EU’s 20 official languages.…
DUTCH STUDY
BY KEITH NUTHALL
GRANTS worth Euro 1.35 million have been awarded by the Dutch government to fund two new research centres carrying out multidisciplinary studies into the prevention, management and treatment of infectious diseases in the Netherlands and developing countries. The centres will be virtual institutions, recruiting researchers from around the country.…
INTERPOL SPORTS
BY KEITH NUTHALL
INTERPOL is to stage an international meeting of police and experts to discuss ways of fighting the growing international traffic in illegal sports performance-enhancing drugs. The agency is particularly keen to collate more information about the problem for its databases, which can be accessed by police forces worldwide.…
EU ADVANCED OPTICAL RESEARCH
BY ALAN OSBORN
THE MANIPULATION of atoms within materials by using optical devices, (such as 3D light field synthesis), is being developed by a consortium of European organisations with Britain paying a leading role. The ATOM3D project is one of a number of “visionary” sciences that the European Union (EU) is funding under its New and Emerging Science and Technology (NEST) scheme for 2004 and is slated to receive funding of around Euro 1 million.…